使闭塞
发表于 2025-3-26 23:38:59
Nonalcoholic Fatty Liver Disease Post-Liver Transplantation,ion resulting in cardiovascular events—which is considered today the leading cause of death following liver transplantation in NASH recipients, surpassed only by sepsis. Patients with NASH cirrhosis should be carefully evaluated and selected for liver transplantation, and metabolic risk factors should be treated aggressively.
fatty-acids
发表于 2025-3-27 04:35:20
https://doi.org/10.1007/978-3-658-14428-9pear to have a major impact on graft survival. De novo diseases specific to LT recipients may also appear after LT in both adults and children. Early recognition of recurrent disease and de novo conditions will improve the survival of LT recipients.
善于
发表于 2025-3-27 08:46:24
http://reply.papertrans.cn/29/2813/281259/281259_33.png
昏迷状态
发表于 2025-3-27 13:04:59
http://reply.papertrans.cn/29/2813/281259/281259_34.png
不真
发表于 2025-3-27 13:37:18
Overview: Disease Recurrence After Liver Transplantation,pear to have a major impact on graft survival. De novo diseases specific to LT recipients may also appear after LT in both adults and children. Early recognition of recurrent disease and de novo conditions will improve the survival of LT recipients.
灯丝
发表于 2025-3-27 21:51:08
http://reply.papertrans.cn/29/2813/281259/281259_36.png
PAD416
发表于 2025-3-28 01:56:01
Recurrence of Autoimmune Hepatitis After Liver Transplantation,in the graft of those grafted for other indications. Originally termed de novo autoimmune hepatitis, some now believe this is better termed plasma cell hepatitis and is a form of rejection. Treatment is with corticosteroids or modification of immunosuppression.
adroit
发表于 2025-3-28 02:49:41
http://reply.papertrans.cn/29/2813/281259/281259_38.png
ALIEN
发表于 2025-3-28 06:51:38
http://reply.papertrans.cn/29/2813/281259/281259_39.png
裹住
发表于 2025-3-28 13:59:33
HCV Recurrence: Predictors and Outcomes After Liver Transplantation,). Reinfection occurs invariably in those who are viremic at transplantation resulting in recurrent disease with uncertain outcome. Several factors, in particular, donor age, have shown to influence the natural history of HCV post-transplantation. Understanding which factors determine disease and pa